The impact of family history of breast cancer and cancer death on women's mammography practices and beliefs

Tracy, Kelly A.; Quillin, John M.; Wilson, Dulaney A.; Borzelleca, Joseph F.; Jones, Resa M.; McClish, Donna K.; Bowen, Deborah J.; Bodurtha, Joann

doi:10.1097/gim.0b013e31817c0355

Cited by 33 publications

(34 citation statements)

References 22 publications

(24 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This finding is consistent with the research showing that loss of a close family member to breast cancer may motivate reattendance and adherence to cancer-screening recommendations (Tracy et al, 2008). By itself, it is a powerful predictor, with results indicating that participants who lost their mothers to breast cancer were over 2 1 2 times more likely to follow up.…”

Section: Discussionsupporting

confidence: 92%

Predicting reattendance at a high-risk breast cancer clinic

et al. 2015

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 92%

Predicting reattendance at a high-risk breast cancer clinic

et al. 2015

View full text Add to dashboard Cite

show abstract

“…They hold less inaccurate beliefs toward cancer treatment, they feel more comfortable with treatment decisions and are more likely to receive adjuvant therapy [6,7,23,24]. The current study confirms that a positive family history influences method of detection and treatment of breast cancer, especially in patients of low SES.…”

Section: Discussionsupporting

confidence: 73%

Impact of a positive family history on diagnosis, management, and survival of breast cancer: different effects across socio-economic groups

Verkooijen

Rapiti

Fioretta

et al. 2009

Cancer Causes Control

View full text Add to dashboard Cite

Background This study aims to investigate whether increased awareness of breast cancer, due to a positive family history (FH), reduces diagnostic, therapeutic, and survival differences between women of low versus high socio-economic status (SES). ]).Conclusion A positive FH of breast cancer may reduce SES differences in access to screening and optimal treatment. However, even with better access to early detection and optimal treatment, women of low SES have higher risks of death from their disease than those of high SES.

show abstract

“…Moreover, noninferiority of survival in individuals with a family history of cancer has been described in colorectal, breast, and prostate cancer. 37-39 Although it remains to be established, reasons for this may include increased cancer surveillance, resulting in presentation at earlier stages of disease, 40,41 improved health-related behavior, 42 or differences in tumor biology and response to therapy.…”

Section: Discussionmentioning

confidence: 99%

Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History

Sud¹,

Thomsen

Sundquist

et al. 2017

JCO

View full text Add to dashboard Cite

PurposeAlthough advances in Hodgkin lymphoma (HL) treatment have led to improved disease-free survival, this has been accompanied by an increased risk of second cancers. We sought to quantify the second cancer risks and to investigate the impact of family history.Patients and MethodsUsing the Swedish Family-Cancer Project Database, we identified 9,522 individuals with primary HL diagnosed between 1965 and 2012. We calculated standardized incidence ratios and cumulative incidence of second cancer in HL survivors and compared the standardized incidence ratios of lung, breast, colorectal, and all second cancers in HL survivors with and without a site-specific family history of cancer. Interactions between family history of cancer and HL treatment were evaluated under additive and multiplicative models.ResultsOverall, the risk of a second cancer in HL survivors was increased 2.39-fold (95% CI, 2.29 to 2.53). The 30-year cumulative incidence of breast cancer in women diagnosed with HL at younger than 35 years of age was 13.8%. We observed no significant difference in cancer risk over successive time periods. The risk of all second cancers was 1.3-fold higher for HL survivors with a first-degree relative with cancer (P < .001), with 3.3-fold, 2.1-fold, and 1.8-fold differences shown for lung, colorectal, and breast cancers, respectively. Moreover, a greater than additive interaction between family history of lung cancer and HL treatment was shown (P = .03).ConclusionHL survivorship is associated with a substantive risk of a second cancer. Notably, the risk is higher in individuals with a family history of cancer. This information should be used to inform risk-adapted therapy and to assist in screening to reduce long-term morbidity and mortality in patients with HL.

show abstract

The impact of family history of breast cancer and cancer death on women's mammography practices and beliefs

Abstract: Purpose: To summarize the impact of a family history of breast cancer on mammography practices and beliefs.Method: Survey data concerning breast health practices and beliefs were utilized for a cross-sectional analysis.

Cited by 33 publications

References 22 publications

Predicting reattendance at a high-risk breast cancer clinic

Predicting reattendance at a high-risk breast cancer clinic

Impact of a positive family history on diagnosis, management, and survival of breast cancer: different effects across socio-economic groups

Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History

Contact Info

Product

Resources

About